Confidential portions of this Exhibit marked as [**] have been omitted pursuant to a request for confidential treatment that has been filed separately with the Securities and Exchange Commission. Amendment to Supply AgreementSupply Agreement • May 20th, 2014 • Actavis PLC • Pharmaceutical preparations
This Amendment to the Supply Agreement (“Amendment”), effective as of May 14, 2014 (the “Amendment Effective Date”), amends that certain Supply Agreement, dated as of November 1, 2010 (the “Agreement”), by and between Ortho-McNeil-Janssen Pharmaceuticals, Inc., a Pennsylvania corporation ((n/k/a Janssen Pharmaceuticals, Inc.), “Janssen”) and Watson Laboratories, Inc., a Nevada corporation (“Watson”, and, together with Janssen, the “Parties”). All terms used herein and not defined shall have the meaning set forth in the Agreement.
